Quick Answer
Exousia Bio, Inc. reported Operating Income of -$56.4 thousand for fiscal year 2023.
Exousia Bio, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2023 | -$56.4K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | -$237.0K | -3495.0% | -645.0% |
| August 31, 2025 | -$31.8K | -632.7% | -555.7% |
| November 30, 2024 | $7.0K | +193.7% | +260.8% |
| August 31, 2024 | -$4.3K | +64.3% | +50.1% |
| February 29, 2024 | -$8.7K | -5.2% | -16.7% |
| November 30, 2023 | -$7.4K | +11.4% | +38.8% |
| August 31, 2023 | -$12.2K | +6.2% | -47.1% |
| February 28, 2023 | -$8.3K | — | +1.6% |
- The most recent figure is from Exousia Bio, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on September 1, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: